German Sovereign

Hella Hueck, the family-owned German car lighting and electronics maker, has set the price range on 5.75m of its shares at between €25 and €28, or €144m at the bottom of the range.

Hella Hueck, the family-owned German car lighting and electronics maker, today (Friday) completed a preliminary sale of shares that will allow it to complete its IPO next week.

German property firm TLG Immobilien successfully placed €360m of its shares on the Frankfurt Stock Exchange on 23 October, in that week’s only IPO in Europe.

Daimler leveraged strong demand for its name among European asset management and private bank buyers to price an A$100m ($88m) three year bond on Wednesday.

Fraport, which operates Frankfurt airport and has stakes in several other airports, has issued a €350m seven year Schuldschein paying a 1.436% coupon.

NRW.Bank’s decision to tweak its approach to green bonds looks to have paid off with its second ever deal in the format on Tuesday, as the agency priced a bond that one lead said was through its secondary curve. But factors other than its attempt to woo dedicated green investors may also have been at play, said the banker.

Grand City Properties, the German housing company registered in Luxembourg, has achieved a high hit rate for its bond tender offer.

Fresenius Medical Care priced its $900m senior unsecured high yield issue in the 144A market on Friday October 24.

German property firm TLG Immobilien successfully placed €360m of its shares on the Frankfurt Stock Exchange on Thursday, in this week’s only IPO in Europe.

SAP, the German software firm, closed syndication of the €7bn bridge facility for its $8.3bn acquisition of US expenses software firm Concur at the end of last week. It was the latest in a series of deals to obtain the participation of all the invited banks, fueling expectations that upcoming deals will also be popular.

An institutional investor in German car manufacturer BMW sold €198m of preferred shares on Monday night, but the deal was unlikely to inspire other block trades, bankers said, as the equity markets remain highly volatile.

Swiss biotech firm Molecular Partners became the latest victim of the recent bout of volatility in Europe’s markets, as it put its planned listing on hold on Tuesday. More deals could yet fail, bankers said.